November 2, 2015
Astellas President Yoshihiko Hatanaka The sakigake fast-track review system is “very useful” as it will help deliver innovative products to patients quickly, Yoshihiko Hatanaka, president of Astellas Pharma, said on October 30, days after the company’s cancer drug was designated...read more